Cleared Traditional

K110273 - AEROVENT PLUS CHC

K110273 is an FDA 510(k) clearance for AEROVENT PLUS CHC, manufactured by Monaghan Medical Corporation. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 129-day FDA review.

K110273 · Monaghan Medical Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
129d
Days
Class 2
Risk

K110273 is an FDA 510(k) clearance for the AEROVENT PLUS CHC. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Monaghan Medical Corporation (Plattsburgh, US). The FDA issued a Cleared decision on June 9, 2011 after a review of 129 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Monaghan Medical Corporation devices

FDA 510(k) Submission Details - K110273

510(k) Number K110273 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2011
Decision Date June 09, 2011
Days to Decision 129 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 140d · This submission: 129d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 409
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K110273.
MINISPACER(R) MDI ADAPTER WITH COUNTER INCREMENTING ACTUATOR
K111570 · Thayer Medical Corporation · Sep 2011
COMP A-I-R
K110860 · Omron Healthcare, Inc. · Sep 2011
ATLANTEAN TRIGGER NEBULIZER
K102719 · Atlantean Corporation · Jul 2011
CONTINUOUS NEBULIZATION TUBE SET (CNTS) TUBING: AG-AS3075 + SYRINGE: AG-AS3085
K103635 · Aerogen, Ltd. · May 2011
FOSHAN CARE MEDICAL NEBULIZER MODEL KYWH2001
K101552 · Foshan Care Medical Technology Co., Ltd. · Mar 2011
SMDIA-1000
K101953 · Southmedic, Inc. · Jan 2011